cremophor el has been researched along with Leukemia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahn, CH; Aszalos, A; Hrycyna, CA; Hwang, M; Licht, T; Pine, PS; Yin, JJ | 1 |
Canada, AL; Ross, HJ; Slater, LM | 1 |
Chuang, LF; Chuang, RY; Israel, M; Zhao, FK | 1 |
3 other study(ies) available for cremophor el and Leukemia
Article | Year |
---|---|
Effect of combination of suboptimal concentrations of P-glycoprotein blockers on the proliferation of MDR1 gene expressing cells.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Calcium Channel Blockers; Cell Division; Cell Membrane; Cyclosporins; Glycerol; Humans; Leukemia; Transfection; Tumor Cells, Cultured; Verapamil | 1996 |
Cyclosporin A enhances paclitaxel toxicity against leukemia and respiratory epithelial cancers.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cyclosporine; Cytokines; Disease Models, Animal; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Glycerol; Growth Substances; Humans; Immunosuppressive Agents; Leukemia; Mice; Paclitaxel; Respiratory Tract Neoplasms; Survival Rate; Treatment Outcome; Tumor Cells, Cultured | 1997 |
Cremophor EL, a widely used parenteral vehicle, is a potent inhibitor of protein kinase C.
Topics: Binding, Competitive; Cell Line; DNA Polymerase II; Drug Carriers; Glycerol; Humans; Kinetics; Leukemia; Phorbol 12,13-Dibutyrate; Protein Binding; Protein Kinase C; Protein Kinases; RNA Polymerase II; Solvents; Tetradecanoylphorbol Acetate | 1989 |